QbD-driven development and evaluation of nanostructured lipid carriers (NLCs) of Olmesartan medoxomil employing multivariate statistical techniques.
Drug Dev Ind Pharm
; 44(3): 407-420, 2018 Mar.
Article
in En
| MEDLINE
| ID: mdl-29048242
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Drug Carriers
/
Nanostructures
/
Olmesartan Medoxomil
/
Lipids
Language:
En
Journal:
Drug Dev Ind Pharm
Year:
2018
Document type:
Article
Affiliation country:
Country of publication: